Ebola vaccine to begin trials in new Guinea center

An Ebola vaccine will begin trials in a new Guinea testing center.
An Ebola vaccine will begin trials in a new Guinea testing center.

A teleconference between Guinean President Alpha Conde, Russian President Vladimir Putin and the rest of the world was recently conducted in order to express thanks to those who have developed the Ebola vaccine in Russia, which has received Russian state registration. 

The teleconference was part of an event, with Minister of Health Veronika Skvortsova and Head of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing Anna Popova, alongside RUSAL President Oleg Deripaska, in attendance.

Skvortsova relayed that the vaccine is ready for field trials, beginning in the Republic of Guinea at the Research and Clinical Diagnostics Center for Epidemiological and Microbiological Studies, a program by RUSAL, who have been in Guinea for more than 10 years. RUSAL has put $10 million into the center, located in Kindia, which will begin to act as a treatment center for other diseases once Ebola is eradicated. An infection hospital, a laboratory, a blood and plasma center and a tentative hospital are all part of the center, which is the largest center meant for treating viral diseases in all of West Africa. 

RUSAL employees have not been infected with Ebola yet, but Popova noted that there was a high rate of infection amongst Guinean medical workers. By government and nongovernment parties working together, Deripaska stated, even the toughest issues will be solvable.

Organizations in this Story


Want to get notified whenever we write about UC RUSAL ?
Next time we write about UC RUSAL, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.